[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Dermal Fillers Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

October 2017 | 194 pages | ID: GCF1BF64CA1EN
Precision Business Insights (PBI)

US$ 4,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Dermal Fillers Market:

Global dermal fillers market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for dermal fillers projected to reach US$ XX Mn by 2023.

Dermal fillers are implants that are regulated as the medical devices by U.S.FDA. Dermal fillers are used as effective treatment for folds correction, wrinkles and deep lines on the face. Dermal fillers can be used for anti-aging practices to remove folds and wrinkles in nasolabial, and cheek area, lines and wrinkles around eye and volume loss in chin. Dermal fillers are the injectable gels that are composed of synthetic and natural substances like hyaluronic acid. Dermal fillers pump and lift the sagged skin for restoring lost collagen because of the aging.

Increase in patients with different cosmetic skin issues like deep lines, wrinkles and scars, diet imbalance are the major factors boosting the revenue growth of the dermal fillers market. As per the World Health Organization (WHO), more than 2 Bn of the global population will be over the age of 60 by the year 2050, WHO stated that the growth of the facial filler market is directly proportional to the growing geriatric population, who experience loss of fluid and collagen in the skin as they grow older, that results in the development of wrinkles on the face and neck areas. Dermal fillers is less painful and non-invasive method for treating various facial problems and aesthetic treatments for other parts of the body. High cost of the procedure and infections associated with dermal fillers is the major market constraint that hinders the growth of the dermal fillers market over the forecast period.

Derma fillers market segmented on the basis of product type, ingredient and distribution channel

On basis of product type, the dermal fillers market is segmented into
  • Absorbable Dermal Fillers
  • Non-Absorbable Dermal Fillers
On basis of ingredient, the dermal fillers market is segmented into
  • Hyaluronic acid (HLA)
  • Poly-L-Lactic Acid (PLA)
  • Calcium hydroxyl apatite (CaH)
  • Polymethylmethacrylate (PMMA)
  • Collagen
  • Others
On basis of distribution channel, the dermal fillers market is segmented into
  • Retail Pharmacies
  • Drug Stores
  • Beauty Clinics
  • Online Pharmacies
The global dermal filler market is expected to grow at significant rate owing to advances in technologies such as injecting techniques and molecular changes adopted in filler materials have brought safe and simple methods in performing dermal fillers to patients. Further, the market is witnessing various acquisitions, collaborations, and mergers among major players. A NAMCS (The National Ambulatory Medical Care Survey) reported that from 1995 to 2003, soft tissue fillers 18.4% constituted office-based cosmetic procedure visits. 90% of office-based cosmetic procedures were performed on Caucasian patients and 10% on non-Caucasian patients. The American Society of Plastic Surgeons in its 2007 Cosmetic Demographics by Patient Ethnicity reported that injectable fillers are one of the three most commonly adopted procedures among, Hispanics, Asian Americans, and African-Americans who seeks cosmetic procedures. As per to the statistics of the American Society of Aesthetic Plastic Surgery, in 2015, dermal filler cosmetic treatments has increased by 8%.

Based on the geographical regions dermal filler market is segmented into five key regions Latin America, North America, Asia-Pacific, Europe, Middle East and Africa. North America holds largest share globally followed by Europe, and Asia Pacific due to the high occurrence of various skin problems. In Asia-Pacific, the Australian and Chinese markets for facial injectable will sustain the fastest growth through 2014. The Asia-Pacific facial injectable market comprising sales of hyaluronic acid (HA) dermal fillers, particle and polymer fillers (PPFs), and collagen fillers will grow significantly due to increased physician adoption of profitable facial injectable treatments in their practices and growing patient demand for less invasive cosmetic procedures.

Some of the players in the dermal fillers market are Galderma (Nestle) (Switzerland), Bioha Laboratories (China), MERZ PHARMA GMBH & CO. KGAA (Germany), Syneron Inc.(U.S.), Allergan plc (Ireland), AQTIS Medical (Canada), and Suneva Medical (U.S.)

In January, 2017, Allergan plc. launched Juvederm First injectable designed for improving quality of skin and lasts up to 9 months with just one treatment session. This new innovative product of Allergan works with unique patented VYCROSS technology

In December 2016, Galderma received U.S.FDA approval for 2 new products that are used to treat nasolabial folds or laugh lines in patients over the age of 21

In 2015, Allergan plc, received approval from the U.S.FDA approval to market its juvederm ultra xc injection used for lip augmentation in adults over the age of 21

In April 2014, Merz Aesthetics, introduced Belotero, innovative hyaluronic acid fillers, provided with and without lidocaine

REPORT OUTLINE:
  • The report provides granular level information about the market size, regional market share and forecast from 2017-2023
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The Report Outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. EXECUTIVE SUMMARY

2. GLOBAL DERMAL FILLERS MARKET INTRODUCTION

2.1. Global Dermal Fillers Market – Taxonomy
2.2. Global Dermal Fillers Market –Definitions
  2.2.1. Product Type
  2.2.2. Distribution Channel

3. GLOBAL DERMAL FILLERS MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Dermal Fillers Market Dynamics – Factors Impact Analysis
3.6. Global Dermal Fillers Market – Regulations
  3.6.1. U.S
  3.6.2. Europe
  3.6.3. Japan
3.7. Global Dermal Fillers Market – Recent Product Launches

4. GLOBAL DERMAL FILLERS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL DERMAL FILLERS MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Absorbable Dermal Fillers
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Non-Absorbable Dermal Fillers
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis

6. GLOBAL DERMAL FILLERS MARKET, BY INGREDIENT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Hyaluronic Acid (HLA)
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Poly-L-Lactic Acid (PLA)
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Calcium Hydroxylapatite (CaH)
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. Polymethylmethacrylate (PMMA)
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis
6.5. Collagen
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.5.3. Market Opportunity Analysis
6.6. Others
  6.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.6.3. Market Opportunity Analysis

7. GLOBAL DERMAL FILLERS MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Retail Pharmacies
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Drug Stores
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Beauty Clinics
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. Online Pharmacies
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis

8. GLOBAL DERMAL FILLERS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. North America
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Europe
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
8.4. Latin America
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
  8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.5.3. Market Opportunity Analysis
8.6. Global Dermal Fillers Market - Opportunity Analysis Index - By Product Type, By Ingredient Type, By Distribution Channel, and Region, 2017 – 2023

9. NORTH AMERICA DERMAL FILLERS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  9.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    9.1.1.1. Absorbable Dermal Fillers
    9.1.1.2. Non-Absorbable Dermal Fillers
  9.1.2. Ingredient Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.2.1. Hyaluronic Acid (HLA)
    9.1.2.2. Poly-L-Lactic Acid (PLA)
    9.1.2.3. Calcium Hydroxylapatite (CaH)
    9.1.2.4. Polymethylmethacrylate (PMMA)
    9.1.2.5. Collagen
    9.1.2.6. Others
  9.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.3.1. Retail Pharmacies
    9.1.3.2. Drug Stores
    9.1.3.3. Beauty Clinics
    9.1.3.4. Online Pharmacies
  9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    9.1.4.1. U.S.
    9.1.4.2. Canada
  9.1.5. North America Dermal Fillers Market - Opportunity Analysis Index - By Product Type, By Ingredient Type, By Distribution Channel, and Country, 2017 – 2023
  9.1.6. North America Dermal Fillers Market Dynamics – Trends

10. EUROPE DERMAL FILLERS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  10.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    10.1.1.1. Absorbable Dermal Fillers
    10.1.1.2. Non-Absorbable Dermal Fillers
  10.1.2. Ingredient Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.2.1. Hyaluronic Acid (HLA)
    10.1.2.2. Poly-L-Lactic Acid (PLA)
    10.1.2.3. Calcium Hydroxylapatite (CaH)
    10.1.2.4. Polymethylmethacrylate (PMMA)
    10.1.2.5. Collagen
    10.1.2.6. Others
  10.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.3.1. Retail Pharmacies
    10.1.3.2. Drug Stores
    10.1.3.3. Beauty Clinics
    10.1.3.4. Online Pharmacies
  10.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.4.1. Germany
    10.1.4.2. UK
    10.1.4.3. France
    10.1.4.4. Spain
    10.1.4.5. Italy
    10.1.4.6. Russia
    10.1.4.7. Poland
    10.1.4.8. Rest of Europe
  10.1.5. Europe Dermal Fillers Market - Opportunity Analysis Index - By Product Type, By Ingredient Type, By Distribution Channel, and Country, 2017 – 2023
  10.1.6. Europe Dermal Fillers Market Dynamics – Trends

11. ASIA-PACIFIC DERMAL FILLERS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    11.1.1.1. Absorbable Dermal Fillers
    11.1.1.2. Non-Absorbable Dermal Fillers
  11.1.2. Ingredient Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.2.1. Hyaluronic Acid (HLA)
    11.1.2.2. Poly-L-Lactic Acid (PLA)
    11.1.2.3. Calcium Hydroxylapatite (CaH)
    11.1.2.4. Polymethylmethacrylate (PMMA)
    11.1.2.5. Collagen
    11.1.2.6. Others
  11.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.3.1. Retail Pharmacies
    11.1.3.2. Drug Stores
    11.1.3.3. Beauty Clinics
    11.1.3.4. Online Pharmacies
  11.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
    11.1.4.1. Japan
    11.1.4.2. China
    11.1.4.3. India
    11.1.4.4. ASEAN
    11.1.4.5. Australia & New Zealand
    11.1.4.6. Rest of Asia-Pacific
  11.1.5. Asia-Pacific Dermal Fillers Market - Opportunity Analysis Index - By Product Type, By Ingredient Type, By Distribution Channel, and Country, 2017 – 2023
  11.1.6. Asia-Pacific Dermal Fillers Market Dynamics – Trends

12. LATIN AMERICA DERMAL FILLERS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  12.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    12.1.1.1. Absorbable Dermal Fillers
    12.1.1.2. Non-Absorbable Dermal Fillers
  12.1.2. Ingredient Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.2.1. Hyaluronic Acid (HLA)
    12.1.2.2. Poly-L-Lactic Acid (PLA)
    12.1.2.3. Calcium Hydroxylapatite (CaH)
    12.1.2.4. Polymethylmethacrylate (PMMA)
    12.1.2.5. Collagen
    12.1.2.6. Others
  12.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.3.1. Retail Pharmacies
    12.1.3.2. Drug Stores
    12.1.3.3. Beauty Clinics
    12.1.3.4. Online Pharmacies
  12.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.4.1. Brazil
    12.1.4.2. Mexico
    12.1.4.3. Argentina
    12.1.4.4. Venezuela
    12.1.4.5. Rest of Latin America
  12.1.5. Latin America Dermal Fillers Market - Opportunity Analysis Index - By Product Type, By Ingredient Type, By Distribution Channel, and Country, 2017 – 2023
  12.1.6. Latin America Dermal Fillers Market Dynamics – Trends

13. MIDDLE EAST & AFRICA DERMAL FILLERS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  13.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    13.1.1.1. Absorbable Dermal Fillers
    13.1.1.2. Non-Absorbable Dermal Fillers
  13.1.2. Ingredient Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.2.1. Hyaluronic Acid (HLA)
    13.1.2.2. Poly-L-Lactic Acid (PLA)
    13.1.2.3. Calcium Hydroxylapatite (CaH)
    13.1.2.4. Polymethylmethacrylate (PMMA)
    13.1.2.5. Collagen
    13.1.2.6. Others
  13.1.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.3.1. Retail Pharmacies
    13.1.3.2. Drug Stores
    13.1.3.3. Beauty Clinics
    13.1.3.4. Online Pharmacies
  13.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    13.1.4.1. Gulf Cooperation Council (GCC) Countries
    13.1.4.2. Israel
    13.1.4.3. South Africa
    13.1.4.4. Rest of MEA
  13.1.5. MEA Dermal Fillers Market - Opportunity Analysis Index - By Product Type, By Ingredient Type, By Distribution Channel, and Country, 2017 – 2023
  13.1.6. MEA Dermal Fillers Market Dynamics – Trends

14. COMPETITION LANDSCAPE

14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  14.2.1. Galderma (Nestle) (Switzerland)
  14.2.2. Bioha Laboratories (China)
  14.2.3. MERZ PHARMA GMBH & CO. KGAA (Germany)
  14.2.4. Syneron Inc.(U.S.)
  14.2.5. Allergan plc (Ireland)
  14.2.6. AQTIS Medical (Canada)
  14.2.7. Suneva Medical (U.S.)

15. RESEARCH METHODOLOGY

16. KEY ASSUMPTIONS AND ACRONYMS


More Publications